<DOC>
	<DOCNO>NCT02108184</DOCNO>
	<brief_summary>Comparison eradication rate sequential therapy versus concomitant therapy treatment Helicobacter pylorus infection Korea . single center , randomize trial 1 . ( pantoprazole 40 mg + amoxicillin 1.0g + clarithromycin 500 mg + metronidazole 500 mg ) twice 10 day 2 . ( pantoprazole 40 mg + amoxicillin 1.0g + clarithromycin 500 mg + metronidazole 500 mg ) twice 14 day 3 . ( pantoprazole 40 mg + amoxicillin 1.0g ) twice 5 day subsequent pantoprazole 40mg + clarithromycin 500 mg + metronidazole 500 mg ) twice 5 day 4 . ( pantoprazole 40 mg + amoxicillin 1.0g ) twice 7 day subsequent pantoprazole 40mg + clarithromycin 500 mg + metronidazole 500 mg ) twice 7 day 1st endpoint : Helicobacter pylori eradication rate ( intention treatment , per-protocol ) 2nd endpoint : adverse event ( nausea , vomit , dizziness , bitter sense ) drug compliance</brief_summary>
	<brief_title>Comparison Eradications Rates Sequential Therapy Versus Concomitant Therapy</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Helicobacter Infections</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>20~80 patient agreement inform consent H.pylori positive ( biopsy , CLO ) Peptic ulcer disease , mucosa associate lymphoid tissue lymphoma , Post endoscopic submucosal dissection status due early gastric cancer H.pylori eradication history severe hepatic , renal , cardiac failure pregnancy , participant study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>helicobacter eradication rate</keyword>
</DOC>